17-beta-estradiol
Back Pain
Duke UniversityPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
15 Active assets in the Back Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Medical University of Lublin | Phase 4 | BBB |
Oxycodone Grünenthal GmbH | Phase 4 | BBB |
Celestone Pain Management Center of Paducah | Phase 4 | BB |
Glucosamine Sulphate Ferrosan AS | Phase 4 | BB |
LEAN Napp Pharmaceuticals Limited | Phase 4 | BB |
View all 41 →
Same molecule, other indications
17-beta-estradiol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →